Small Scale Bioreactors Market Overview by 2035
Read More: https://www.rootsanalysis.com/....reports/mini-bioreac
The small scale bioreactors market, which includes mini bioreactor and micro bioreactor, is estimated to be worth $1.2 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 8% during the forecast period. With several blockbuster therapies (such as Humira®, Rituxan®, Lantus®, Avastin®, Herceptin® and Remicade®) and a robust pipeline of product / therapy candidates, the global market of biopharmaceuticals is anticipated to witness significant growth in the next few years.
Like
Comment
Share
